Strategic Growth Tecomet’s recent merger with Orchid Orthopedic Solutions creates a larger global footprint and expanded capabilities, signaling opportunities to cross-sell integrated contract manufacturing services to a broader customer base in medical devices, orthopedics, and related markets.

Quality Leadership Award recognition for HSE initiatives reinforces Tecomet’s commitment to safety and quality, making the firm an attractive partner for customers with stringent regulatory and quality requirements seeking reliable suppliers.

Aerospace and Defense Beyond medical devices, Tecomet’s experience with high-precision manufacturing positions it to pursue diversified programs in aerospace and defense sectors, appealing to current clients seeking multi-industry suppliers and expansion of contracts.

Digital Infrastructure Utilization of modern tech stack including Power Apps, Azure, Salesforce, and Hyperion indicates scalable processes and data-driven operations, enabling targeted enterprise sales with visibility into production capacity, lead times, and quality metrics.

Leadership continuity Executive leadership change with a new CEO in 2023, coupled with the Cardinal Health acquisition in 2021, suggests stability in strategic direction while maintaining legacy relationships, ripe for renewing or expanding enterprise agreements with health system and contract manufacturers.